Health equity is the state in which everyone has fair and just opportunities to attain their highest level of health. The field of human genomics has fallen short in increasing health equity, largely because the diversity of the human population has been inadequately reflected among participants of genomics research. This lack of diversity leads to disparities that can have scientific and clinical consequences. Achieving health equity related to genomics will require greater effort in addressing inequities within the field. As part of the commitment of the National Human Genome Research Institute (NHGRI) to advancing health equity, it convened experts in genomics and health equity research to make recommendations and performed a review of current literature to identify the landscape of gaps and opportunities at the interface between human genomics and health equity research. This Perspective describes these findings and examines health equity within the context of human genomics and genomic medicine.

健康公平是指每个人都有公平、公正的机会达到最高健康水平的状态。人类基因组学领域在提高健康公平性方面存在不足，很大程度上是因为基因组学研究的参与者没有充分反映人口的多样性。这种多样性的缺乏导致了可能产生科学和临床后果的差异。实现与基因组学相关的健康公平需要付出更大的努力来解决该领域内的不平等问题。作为国家人类基因组研究所 (NHGRI) 促进健康公平承诺的一部分，它召集了基因组学和健康公平研究领域的专家提出建议，并对当前文献进行了审查，以确定界面上的差距和机遇。人类基因组学和健康公平研究之间的关系。本视角描述了这些发现，并在人类基因组学和基因组医学的背景下研究了健康公平性。